Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 5, 2005, Pages 746-751

  Shim, Jaejun ^a   Kim, Byung Ho ^a,b   Kim, Nam Hoon ^a   Dong, Seok Ho ^a   Kim, Hyo Jong ^a   Chang, Young Woon ^a   Lee, Joung Il ^a   Chang, Rin ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Hepatitis B core antibody; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOUTH KOREA; VIRUS CARCINOGENESIS;

EID: 19544382056     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03747.x     Document Type: Article

References (23)

1. Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma. J. Korean Med. Sci. 1998; 13: 306-10.
2. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect. Dis. 2002; 2: 479-86.
3. Chan HL, Tsang SW, Leung NW et al. Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection. Am. J. Gastroenterol. 2002; 97: 1211-15.
4. Yuki N, Nagaoka T, Yamashiro M et al. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 2003; 37: 1172-9.
5. Dickson RC, Everhart JE, Lake JR et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology 1997; 113: 1668-74.
6. Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 2002; 347: 168-74.
7. Okada S, Sato T, Okusaka T et al. Past exposure to hepatitis B virus as a risk factor for hepatocellular carcinoma in patients with chronic liver disease. Br. J. Cancer 1998; 77: 2028-31.
8. Yu MC, Yuan JM, Ross RK, Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 1997; 25: 226-8.
9. Yano Y, Yamashita F, Sumie S et al. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan. Am. J. Gastroenterol. 2002; 97: 156-61.
10. Han YS, Kim BH, Baek IY et al. The change of the etiology, complication, and cause of death of liver cirrhosis in 1990s. Korean J. Hepatol. 2000; 6: 328-39.
11. Jung SH, Kim BH, Joung YH et al. Clinical features of hepatocellular carcinoma in the 1990s. Korean J. Gastroenterol. 2003; 42: 322-9.
12. Koga K. Clinical aspects of cryptogenic hepatocellular carcinoma. Kurume Med. J. 1998; 45: 105-11.
13. Ishii K, Sata M, Furudera S et al. Alcoholic liver disease and hepatitis C virus. Alcohol Metab. Liver 1992; 11: 153-7.
14. Takada A, Tsutsumi M. National survey of alcoholic liver disease in Japan (1968-91). J. Gastroenterol. Hepatol. 1995; 10: 509-16.
15. Tsutsumi M, Ishizaki M, Takada A. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis. Alcohol. Clin. Exp. Res. 1996; 20: 758-62.
16. Adami HO, Hsing AW, McLaughlin JK et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int. J. Cancer 1992; 51: 898-902.
17. Ohhira M, Fujimoto Y, Matusmoto A, Ohtake T, Ono M, Kohgo Y. Hepatocellular carcinoma associated with alcoholic liver disease: a clinicopathological study and genetic polymorphism of aldehyde dehydrogenase 2. Alcohol. Clin. Exp. Res. 1996; 20 (Suppl. 9): 378A-82A.
18. Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1349-54.
19. Bugianesi E, Leone N, Vanni E et al. Expanding the natural history of nonalcoholic steeatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002; 123: 134-40.
20. Jung SH, Kim BH, Dong SH et al. Clinical features of Korean patients with autoimmune hepatitis diagnosed since. Korean J. Gastronenterol. 2001; 37: 362-9.
21. Hyun JG, Paik SW, Lee JH et al. Clinical features of autoimmune hepatitis in Korea. Korean J. Gastroenterol. 1999; 33: 653-61.
22. Hahm KB, Shin YJ, Yim DS et al. Pi phenotype of α1-antitrypsin in patients with chronic liver disease and primary hepatocellular carcinoma. Korean J. Gastroenterol. 1993; 25: 321-9.
23. Lee JS, Seo KD, Kang DH, Song GA, Cho M, Yang US. Hepatocellular carcinoma in primary biliary cirrhosis: a case report. Korean J. Hepatol. 2000; 6: 519-23.